Clinuvels breakthrough drug SCENESSE® (afamelanotide 16mg), has been approved in the European Union for the treatment of a severe skin condition called erythropoietic protoporphyria (EPP). This is good news because SCENESSE® is very effective in Vitiligo, a skin disease where the body destroys its own color cells. US approval cannot be far behind, and once available in the US market, it can be used off-label for Vitiligo! Stay tuned.
Good news for Vitiligo Sufferers!
Love this Post? Spread the World